Challenging your mind, through games and learning new skills, may help reduce your risk of dementia, according to the ...
Biogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest ...
Alzheimer's Association CEO and president Joanne Pike shares some recommendations on which foods to eat, and which foods to ...
A healthy brain may help protect thinking and memory skills from the early effects of Alzheimer's disease, a new study has ...
As Natalie Morales gets older, conversations about brain health “hit hard.” In an exclusive interview with PEOPLE, the CBS ...
Preclinical AVB-406 data presented in three oral presentations demonstrate the power of the vMiXTM RNAi platform and support planned clinical initiation for Alzheimer’s disease by the end of 2026 Prec ...
Biogen shares are down nearly 3% after the company’s experimental drug for Alzheimer's disease failed to meet its main goal of showing that higher doses produced greater benefits for patients. The ...
Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate ...
Investor's Business Daily on MSN
Biogen is celebrating a first in Alzheimer's disease, but investors are leery
Biogen unveiled mixed results Thursday for its tau-targeting Alzheimer's treatment, leading the stock to drop.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results